Publications

Research Publications

Our team's contributions to scientific literature and regulatory research

Biosecurity

Evolving intellectual property landscape for AI-driven innovations in the biomedical sector

Poddar A and Rao SR

Front. Artif. Intell. (2024) 7:1372161

2024 View Paper

Biotechnology

Biomarkers for Cardiovascular diseases

Agiesh kumar Balakrishna Pillai, Vignesh Mariappan and S R Rao

Pharma focus Asia Issue 54 pages 13

2024 View Paper

Biosecurity

Pseudovirus technology in global health: A critical need for robust biosecurity measures

Poddar A and Rao SR

Journal of Biosafety and Biosecurity 6 (2024) 223–224

2024 View Paper

Biotechnology

Exposure to polyethylene microplastics exacerbate inflammatory bowel disease

Souvik Ghosal, Sagar Bag, S. R. Rao and Sudipta Bhowmik

Royal Society of Chemists (RSC Adv.), 2024, 14, 25130-25148

2024 View Paper

COVID-19

Grappling Covishield fear in India: the urgent need for strong countermeasures to build vaccine confidence

Poddar A and Rao SR

The Lancet Regional Health - Southeast Asia, (2024) Volume 27, 100447

2024 View Paper

COVID-19

Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses

Balakrishna Pillai A, JeanPierre AR, Mariappan V, Ranganadin P, S R Rao

Cell Stress Chaperones. 2022 May;27(3):189-195. (IF:3.7)

2022 View Paper

COVID-19

An Overview Of Potential Biomarkers For The Early Prediction Of Sars-Cov-2 Disease Outcome

Vignesh M, Manoharan PS, Pajanivel R, Lokesh S, Rao S.R, Agieshkumar B Pillai

Microbial Pathogenesis 158: 105057, 2021 Jun 18 (IF: 3.8)

2021 View Paper

COVID-19

COVID 19 Pandemic – Frontline Experiences And Lessons Learnt From A Tertiary Care Teaching Hospital

V Nirmal Coumare, Swati Jayant Pawar, PS Manoharan, R Pajanivel, Lokesh Shanmugam, Hemanth Kumar, Abhijit V Boratne, Balanehru Subramanian, Joshy M Easow, B Sivaprakash, R Kalaivani, K, Renuka, S Prabavathy, Kripa Angeline, Agieshkumar Balakrishna Pillai, SR Rao

Frontiers Public Health 9:673536. doi:10.3389/fpubh.2021.673536 (IF: 3.5)

2021 View Paper

COVID-19

Angiotensin-Converting Enzyme 2 (Ace2): A Protective Factor In Regulating Disease Virulence Of Sars-Cov-2?

Vignesh M, Rao SR, Agiesh Kumar.B

IUBMB Life, 2020; 72(12):2533-2545. (IF: 3.9, 12 Citations)

2020 View Paper

Books & Monographs

Comprehensive books and monographs authored by our team

Viral Hemorrhagic Fevers: Epidemiology, Pathogenesis, Management, and Preparedness

Agiesh Kumar Balakrishna Pillai, Sunil V Manjila, S R Rao

1st Edition - June 1, 2025

Biotechnology and Development: Challenges and Opportunities for Asia

Sachin Chaturvedi and S.R. Rao (eds)

Academic Foundation, New Delhi and ISEAS, Singapore. 2004

Animal Biotechnology: Vaccines and Diagnostics – Markets and Investment opportunities

Dinaker Raj, S.R.Rao and S.Tilagar

Astral Publications Delhi, 300pp

Research Publications

Evolving intellectual property landscape for AI-driven innovations in the biomedical sector

Biomarkers for Cardiovascular diseases

Pseudovirus technology in global health: A critical need for robust biosecurity measures

Exposure to polyethylene microplastics exacerbate inflammatory bowel disease

Grappling Covishield fear in India: the urgent need for strong countermeasures to build vaccine confidence

Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses

An Overview Of Potential Biomarkers For The Early Prediction Of Sars-Cov-2 Disease Outcome

COVID 19 Pandemic – Frontline Experiences And Lessons Learnt From A Tertiary Care Teaching Hospital

Angiotensin-Converting Enzyme 2 (Ace2): A Protective Factor In Regulating Disease Virulence Of Sars-Cov-2?

Books & Monographs

Viral Hemorrhagic Fevers: Epidemiology, Pathogenesis, Management, and Preparedness

Biotechnology and Development: Challenges and Opportunities for Asia

Animal Biotechnology: Vaccines and Diagnostics – Markets and Investment opportunities

50+

15+

10+

5+

Interested in Our Research?